 |
Autologous CD4+/CD8+ T cells transduced with lentiviral vector directed against the NY-ESO-1 protein |
|---|---|
| Trade Name | |
| Orphan Indication | Soft tissue sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-28 00:00:00 |
| Sponsor | Adaptimmune, LLC;Two Commerce Square, 2001 Market Street;Philadelphia, Pennsylvania, 19103 |
